Gibson Dunn Deepens European Restructuring Platform With Addition of Leo Plank and Sacha Lürken in Germany
Firm News | June 2, 2026
Gibson Dunn has further strengthened its premier Business Restructuring and Reorganization Practice Group and European presence with the addition of leading restructuring lawyers Leo Plank and Sacha Lürken in Munich.
Leo joined the firm this week and brings more than two decades of experience advising on complex cross-border financial restructurings and insolvency matters across Germany and Europe.
Sacha is a senior restructuring lawyer with extensive creditor-side experience in cross-border insolvency and restructuring matters, including for financial institutions and in German bond restructurings. He will join the firm in the coming weeks.
“Leo and Sacha’s arrival marks the continued expansion of our global restructuring practice. In 2025, we significantly grew our capabilities in the U.S. and across Europe to meet the increasing demand from large European-based mandates,” said Scott Greenberg, Global Chair of Gibson Dunn’s Business Restructuring and Reorganization Practice Group. “Leo and Sacha’s reputation and leadership across the German and broader European restructuring markets make them ideally positioned to drive that strategy, and their experience is invaluable to our clients navigating complex financial challenges globally.”
Jean-Pierre Farges, Head of the Business Restructuring and Reorganization Practice Group in Europe, added: “Leo and Sacha are a dynamic and highly respected team whose arrival deepens our European and German platform. Their strategic market insight, team-building ability, and strong client relationships further position us to meet growing client demand across the continent.”
“We are delighted to have Leo and Sacha join our team in Germany. Their arrival demonstrates the firm’s commitment to growing strategic areas of our global practice—and to giving our clients an exceptional team on the ground in Munich and Frankfurt,” said Benno Schwarz, Partner in Charge of Gibson Dunn’s Munich office.
“We are excited to join Gibson Dunn at a pivotal moment for the restructuring market, as companies rethink their capital structures and business models,” said Leo. “The firm’s global platform, deep relationships with financial institutions, and strategic vision for Europe align with our ambitions to expand a leading restructuring platform in Germany and across Europe. We look forward to working with Scott, Jean-Pierre, and the exceptional team to further strengthen the firm’s leading restructuring practice.”
Gibson Dunn’s Business Restructuring and Reorganization Practice Group—renowned for handling some of the world’s largest and most complex matters and for its leading position in the U.S. and Europe—has continued to expand its global footprint. Leo’s arrival follows the additions of Lisa Stevens in 2024 and Chris Howard and Presley Warner in 2025—partners who have helped build one of London’s most respected restructuring teams.
The London team has advised on several of the most significant U.K. and cross-border matters in recent years, including Oriflame’s recapitalization and Ardagh Group’s debt restructuring. The practice also has a strong presence in France, where it has advised on major transactions, including the €24 billion restructuring of Altice France and the €9 billion restructuring of Netceed.
About Leo Plank
Leo has advised on major cross-border restructurings, including the multibillion-euro restructurings of Agrokor d.d. in Croatia and HETA Asset Resolution AG in Austria, as well as many of the largest LBO restructurings in Germany. He has extensive experience in complex German financial restructurings and has played a leading role in matters involving Tele Columbus, Rodenstock, A.T.U., Apcoa, IVG, Galapagos, Leoni, and Flint, among others.
About Sacha Lürken
Sacha served as a partner at an international law firm in Germany for more than 15 years. His experience includes leading roles in matters involving Wirecard, Hertz, Steinhoff, SolarWorld, Scholz, Prokon, IVG, and Q-Cells, among others.